Assaf Barnea

He leads Sanara Ventures, an Israeli based healthcare innovation fund, backed by Phillips and Teva, since its inception in 2015. Mr. Barnea is also the Managing Partner of Sanara capital, a follow-on fund to Sanara ventures that invests in Digital Health, Medical Devices & Bio-Convergence companies, and a recognized keynote speaker, sharing his views and vision in various healthcare and digital health conferences across the globe. In addition to leading Sanara, Mr. Barnea chairs the Life Science Advisory Board at The Israel Export Institute, on behalf of the Israeli government, promoting and advancing the export of Israeli technologies in the medical, biotech, pharma and digital fields in global markets. A valued consultant, Mr. Barnea was an advisor to the World Bank’s IFC venture capital team and a co-founder of the IFC’s Tech Emerge initiative; a unique acceleration platform that connects healthcare startups from around the world with leading corporations and hospitals in emerging economies. On December 2018, Tech Emerge Health has won the world bank group president’s award for innovation.Formerly, Mr. Barnea was one of the founders of CardioSense, a MedTech startup company that developed a probe for early shock detection in various medical settings.